1. Drug hepatotoxicity from a regulatory perspective;Senior;Clin Liver Dis,2007
2. Guidance for Industry: Drug-Induced Liver Injury: Premarketing Clinical Evaluation. 2009. (Accessed at http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM174090.pdf).
3. Olson S, Robinson, S, Giffin, R. Accelerating the Development of Biomarkers for Drug Safety: Workshop Summary. http://wwwiomedu/Reports/2009/BiomarkersDrugSafetyaspx
4. AGA technical review on the evaluation of liver chemistry tests;Green;Gastroenterology,2002
5. Hepatic glycogenosis: an underrecognized source of abnormal liver function tests?;Sayuk;Dig Dis Sci,2007